It Took a Text From Joe Rogan. Now Psychedelics Are a Federal Research Priority.
President Trump signed an executive order on April 18 directing the FDA to fast-track review of psychedelic therapies and committing $50 million to ibogaine research. The psychedelics community is cautiously optimistic, and watching closely. President Donald Trump signed an executive order on Saturday directing federal agencies to accelerate research into psychedelic therapies and allocating $50…
You might be interested in
Kratom Crackdown Signals New Drug Policy Shift
As federal cannabis rescheduling looms on the horizon and more states across the country begin rolling out regulations for legal psychedelic therapy, health officials have increasingly been targeting a centuries-old psychoactive plant from Southeast Asia with newly introduced measures of prohibition. Kratom is a leafy green botanical native to Southeast Asia that acts on the…
You might be interested in
Rosin, Raids and Risk: Spain’s New Cannabis Frontier
From home labs and deadly butane blasts to solventless rosin, police raids, and a legal gray zone, Spain is entering a more potent and more volatile phase of cannabis culture. On a cold night in late January 2025, a home lab in Espinardo (Murcia) ended in tragedy. Two young men were killed when a butane-based…
You might be interested in
Cheech Marin Is Talking to Sandwiches in a Jimmy John’s Ad. Cannabis Culture Has Officially Gone Mainstream.
Jimmy John’s Dream Rotation campaign doesn’t wink at cannabis culture. It hires Cheech Marin, lets him argue with a sandwich and makes Kal Penn’s ideal 4/20 a gym session and a book. The wall is down. Cheech Marin is sitting, holding a sandwich. He looks at it the way a man looks at something he…
You might be interested in
You Went Legal. The Federal Government Rewarded You With a 70% Tax Rate.
Legal cannabis operators paid $2.24 billion in excess federal taxes in 2025. The illicit market paid zero. That is not a coincidence. That is policy. If you run a legal cannabis business and you feel like the system is working against you, the numbers back you up. A refreshed analysis from Whitney Economics, released this…
You might be interested in
Why Some Heavy Cannabis Users Can’t Stop Throwing Up, According to New Research
A survey of more than 1,100 people with suspected or diagnosed CHS offers one of the clearest looks yet at the condition, including a notable finding: exclusive vape cartridge users reported symptoms appearing sooner than exclusive flower smokers. By Riley Kirk, PhD and Codi Peterson, PharmD Cannabis is known for helping fight nausea. It can…
You might be interested in
Revelry Marks 10 Years With Two Major New York Cannabis Events
A decade in, one of New York’s most important cannabis gatherings is doubling down. New York’s cannabis industry doesn’t have many constants. Markets shift, regulations change, and operators come and go. But for the past decade, one thing has remained steady: Revelry. Now, the platform behind some of the state’s most recognizable cannabis gatherings is…
You might be interested in
Inside Hypno World and the Push Toward High-THC Cannabis Genetics
Cannabis brands don’t usually build worlds. They build catalogs, menus, drops. Hypno Seeds has been moving in a different direction—treating cannabis less like a product and more like a system of ideas, visuals, and experiences. That direction takes a more literal form with Hypno World, an interactive extension of the brand that expands its identity…
You might be interested in
Psychedelic Reform Is Spreading Faster Than Anyone Expected. The Movement Is Trying Not to Blow It.
Psychedelic legislation is moving through more state capitols simultaneously than at any point in history. The question is not whether reform is coming. It is whether it will be done right. In March 2026, Oregon signed into law significant modifications to its psilocybin services program, the first regulated psychedelic access system in the country, now…
You might be interested in
‘Cannabis Is a Tool, Not an Escape.’ Two Iraqi-American Brothers Built a $180 Million Brand Around That Idea.
Ali and Muha Garawi built Muha Meds from a $15,000 startup into one of cannabis’s most dominant brands — without outside money, without losing the culture and without losing each other. “A lot of people wait for the right moment or for some perfect circumstance,” says Muha Garawi, “but when you have a background like…
You might be interested in
